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For social interventions aimed at improving nutrition behavior evidence from randomized trials is essential but cannot be
the only approach of research activities. Interventions on dietary habits require considerations on food security, economic
and environmental sustainability, and a broad meaning of wellbeing which includes, but also goes beyond, health effects.
The model of research in nutrition requires a new consideration of observational studies, mainly through different
analytical models. Nutrition and food studies need research programs where medical (nutrition and health), psychology
(how we behave), economics (how resources are used and their impact on wellbeing) and sociology (how social
determinant shape behavior) collaborate.
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INTRODUCTION
Diets high in animal fats and low in unsaturated fats have
been associated an increased risk of coronary heart disease
(CHD) and cardiovascular diseases (CVD) in animal and
human studies (Kato et al., 1973; Grundy et al., 1982; Keys
et al., 1984; Keys et al., 1986). In the last few decades, recom-
mendations to substitute animal fats rich in saturated fatty
acids (SFA) with polyunsaturated fatty acids (PUFA), have
been the main focus of several dietary guidelines targeted to
reduce CHD and CVD morbidity and mortality (Aranceta and
Perez Rodrigo, 2012). The main reason for that advice was the
raising effect of dietary SFA on blood total cholesterol (TC)
and low density lipoprotein cholesterol (LDL C), which are
known risk factors for CHD and CVD) : However, not all stud-
ies had supported the relation between SFA and CHD or CVD
(Kushi et al., 1985; Ascherio et al., 1996; Gillman et al.,
1997; Mozaffarian et al., 2004; Siri Tarino et al., 2010) and
conflicting results recently emerged on the benefit of substitut-
ing SFA with PUFA on major cardiovascular outcomes
(Mozaffarian et al., 2010; Ramsden et al., 2013; Rizos et al.,
2013). In addition, over the last years a more complex picture
concerning risk factors for CVD came out. Beyond the tradi-
tional serum/plasma markers of CHD risk, i.e., TC, LDL C,
high-density lipoprotein cholesterol (HDL C), and triacylgly-
cerols (TAG), other biomarkers as apolipoprotein (Apo) AI,
and B, the main protein components of HDL C and LDL C,
respectively, and lipoprotein a (Lp(a), have been suggested to
be valid, if not better, risk predictors (Kronenberg et al., 1999;
Walldius et al., 2001; Blaha et al., 2008; McQueen et al.,
2008).
Recommending the substitution of SFA with PUFA
requires more scientific evidence on a qualitative, and not just
quantitative, standpoint. Better evidence about dietary risk fac-
tors does not fulfill the requirements for the use of research for
policy making. While it is widely accepted that nutrition may
health status and wellbeing, the gap between research and pol-
icy making appears very wide. Policy makers would need sci-
entific evidence to motivate action and legitimize choices in
arenas that are often crowded by several conflicting stakehold-
ers and fanatical opinions (Ioannidis, 2013). Unfortunately
available evidence on costs and benefits of specific interven-
tions is often lacking or at least inadequate (Gyles et al.,
2012). We will here try to suggests possible reasons of this
gap and offer some suggestion for future directions.
The Value and Limits of the Medical Model of Nutrition
Interventions
The scientific model generally followed by nutrition
research is strongly influenced by medical paradigms and,
more recently, by the broad acceptance of the evidence-based
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medicine model. Robust evidence, typically based on random-
ized trials, provides the most valuable proof of the impact of
specific interventions on human health. This model, well
established worldwide, is typically focused on the evaluation
of specific interventions investigated in rather manipulated
environments to guarantee the constancy of other factors and
thus reduce the risk of confounding.
This model is being increasingly appreciated and used by
social scientists who are keen to improve the rigour of the evi-
dence that randomized experiments can produce, both in the
field (Duflo, 2008; Kremer and Glennester, 2012) and in the
lab (Murray et al., 2004; Falk and Heckman, 2009). However,
in many areas of social sciences the value of experiments is
still debated for at least two major reasons. The first concerns
the feasibility of unbundling social action. Often, if not
always, social policies entail a variety of interconnected inter-
ventions that cannot be disentangled into specific components
amenable to experiments. This is often due to the nature of
social actions where more interventions are concurrently
designed and implemented to deal with problems, but it is also
due to the nature of policy processes favoring solutions where
multiple interventions are adopted (e.g., in order to get suffi-
cient political support). While the registration of pharmaceuti-
cals is based on specific documentation produced for each
compound and for specific indications, social interventions are
not subjected to this regulatory framework (see below).
The other reason is the limits of external validity of proofs
of social interventions. While the issue of whether results of
randomized trials are generalizable is indeed serious even in
medicine, when interventions strongly interact with social and
economic conditions, which greatly vary in space and time,
the issue of external validity (or generalizability) becomes of
paramount importance. Let’s take for example diet studies;
how can results from southern Europe be applicable to Asian
populations, given the radically different cultural, social and
natural contexts?
For social interventions, the introduction of a new tax or the
labeling of products, randomized trials can be very beneficial
but cannot be the only focus of research activities. It is a prob-
lem of feasibility and costs. Randomized trials may be techni-
cally unfeasible, for example, because it would be impossible
to randomize people to different taxation regimes, or they may
be politically unfeasible because randomization, by differenti-
ating individuals, creates formidable obstacles to the policy
process that, in democratic regimes, need popular support for
collective action. Probably, cluster randomized studies may be
more feasible and indeed, as the experience of experiments in
developing countries show, may be used as a major research
design to provide inputs to policy making (Kremer et al.,
2012). However, despite the potential of field experiments, it
is unrealistic to assume that evidence for policy making can
mainly derive from randomized experiments due to these fea-
sibility issues. The other problems with randomized trials con-
cerns costs. The medical model is hardly replicable in the field
of nutrition because of the extreme difficulty to fund studies
that are very costly. In simple terms, in social sciences there is
not the business model of the pharmaceutical sector, where
huge and risky investments are rewarded by the extra-profits
of eventual monopoly (although temporary) granted by pat-
ents. In sum, while more randomized trials are surely
extremely useful to better understand the health effects of spe-
cific diet changes and some nutrition interventions, other
research designs are needed to produce evidence on the overall
impact of social interventions (Ioannidis, 2013).
A Call for Interdisciplinary Action
Interventions aimed at changing our diets, although based
on sound scientific evidence on physiology and pathology,
should fully consider that eating and drinking behaviors are
deeply embedded in social, economic and cultural contexts
and that interventions tend to be nonmedical in nature. In addi-
tion, our societies strongly endorse basic liberal principles that
limit the space of strong restrictions (e.g., banning categories
of food) and subject decisions to approval of democratic insti-
tutions. This is not a minor issue and is often neglected by the
scientific community. While in Europe and the United States,
democratic institutions have given the mandate to technocratic
bodies, namely EMA and FDA, to regulate the access to phar-
maceutical compounds on the basis of safety and efficacy,
food and nutrition policies are likely to remain in the direct
domain of policy making and subjected to direct democratic
accountability. Here it is important to appreciate the difference
between a drug and, for example, a natural product like palm
oil. Collective interventions on the former requires market
authorization aimed at guaranteeing the safety, effectiveness
and quality of the production process for the introduction of a
new product. This authorization is expected to be based on sci-
entific evidence mainly produced by the marketing company
with tests investigating the overall effects of the drug. Impor-
tantly, the drug is a medical intervention whose administration
is justifiable only because of its health improvement effects.
Palm oil, instead, is a product that individuals eat in a variety
of possible meals, is part of cousin traditions in many conti-
nents, with major differences across the globe, partly due to
the conditions of the local natural environment. Most impor-
tantly, it is not used with a medical purpose but in a set of daily
activities that include preparing meal and eating, with all their
meaning and rituals, and meet a demand for food as source of
energy and personal pleasure. The main implication of these
major differences is that the type of scientific evidence to offer
guidance to policymakers can hardly be the same. Instead, the
medical model tends to dominate the investigation of interven-
tions that concern eating. While this approach to research is
essential to produce knowledge on the effects of diets on
health so that better and larger trials are urgently needed (Ioan-
nidis, 2013), how to change nutrition habits need to be
addressed through a full understanding of the psychological
and social conditions of nutrition behaviors.



























The Contribution of the Social Sciences
A number of disciplines, with their theories and empirical
methods, can contribute to make a new agenda on nutrition
and food policies. We are here listing some of the research tra-
jectories appearing more fruitful. A major area of research is
natural experiments. Events outside the control of researchers,
as changes in food prices, new taxation regimens, regulations
about labeling, just to mention a few, produce the possibility
to identify interventions and counterfactuals that can be used
to estimates the effects of interventions. These studies use
changes in policies or other events to generate evidence about
the effects of interventions and actions. Clearly, these studies
cannot rely on randomization and thus create a number of
problems in order to disentangle the effects attributable to
interventions. Nevertheless, recent methodological advance-
ments in the field of policy evaluation have produced statisti-
cal techniques to improve the internal validity of these studies
and, in addition, the natural setting of these studies favor their
generalization. These methods include the use of double dif-
ference models, propensity score matching and discontinuity
regression (Khandaker et al., 2010). While most of these stud-
ies take advantage of natural situations where it is possible to
identify counterfactuals, a simple, better dialogue between the
research community and policymakers can help to produce
evidence along the implementation process of policies. The
basic idea is that policies that are robustly evaluated through
pilot studies, testing, gradual introduction and good monitor-
ing may create actionable scientific knowledge and favor the
use of evidence in the policy making process. The area of
social lab experiments is also promising and complementary
to field experiments. Social lab studies, from those based on
games to the use of neuroimaging, can shed light on how peo-
ple behave and their motivations. Lab experiments are very
flexible and may be easily combined with medical research.
While historically they were mainly restricted to psychology,
now they are widely conducted in several fields of the social
sciences, including economics and political sciences.
Another strategy concerns a research agenda that fully rec-
ognize the complexity of food and nutrition and the conse-
quent need of interdisciplinary teams and approaches.
Experiments and quasi-experiments are very empirical in
nature and often miss understanding the underlying mecha-
nisms of action. Especially when the goal of action is to mod-
ify behavior it appears essential to understand better how
people behave and respond to stimuli. One of the main merit
of economics is to have produced theories about human behav-
ior and to have tested them empirically. While these theories
traditionally rely on strong assumptions about the rationality
of behaviors, more recent contributions, mainly stemming
from the interaction between economics and psychology, have
shown how people may systematically break rational logc
(Kahneman, 2011) and how public policies may leverage these
behaviors to improve wellbeing (Oliver, 2013). For example,
in order to reduce salt consumption, a strategy tested in
England was to give five-hole salt shakers to replace the 17-
hole type routinely used (Shroder and Lyon, 2013).
Nutrition and food studies need research programs where
medical (nutrition and health), psychology (how we behave),
economics (how resources are used and their impact on well-
being), and sociology (how social contexts are shaped and
shape individual behavior) work together. Preliminary exam-
ples come from investigations conducted in early nutrition
(Taveras et al., 2004).
Biomedical sciences are probably the starting point because
health concerns represent the focal justifications of policy inter-
ventions. Specific inputs on the value of nutrients and diets are
on the other hand the bases for any action aimed at changing
nutrition behaviors. Within this context, food production, eco-
nomic well-being and human growth should be connected in a
virtuous circle, hopefully. Then, the contribution of psychology
is fundamental to understand how and why people behave and,
more importantly, what types of interventions may favor desir-
able behavioral changes. Sociology is asked to put behavior in
the social context as culture, social stratification and ties, just to
mention some of the main areas of sociological research, inter-
acts with individual behaviors. Finally, economics is asked to
deal with the issue of finite resources and their efficient alloca-
tion to foster growth and, more importantly, social develop-
ments. The major contribution of economic studies probably
concerns cost-benefit analysis (lato sensu) of interventions, and
today one of the main economic challenges is to combine a vari-
ety of sub fields, including health, agriculture, environment and
trade, all vital to the preservation of life.
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